Prognostic implication of programmed cell death 1 protein and its ligand expressions in endometrial cancer

Monoclonal antibodies targeting programmed cell death-1 (PD-1)/programmed death ligand 1 (PD-L1) demonstrated promising clinical response. The predictive/prognostic value of PD-1/PD-L1 immunohistochemistry (IHC) has been evaluated in many cancer types. However, the prognostic value of PD-1/PD-L1 IHC...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Gynecologic oncology 2018-05, Vol.149 (2), p.381-387
Hauptverfasser:	Kim, Jisup, Kim, Sinae, Lee, Hye Sun, Yang, Wookyeom, Cho, Hanbyoul, Chay, Doo Byung, Cho, Seong Jin, Hong, Soonwon, Kim, Jae-Hoon
Format:	Artikel
Sprache:	eng
Schlagworte:	Endometrial cancer Immunohistochemistry Prognostic factor Programmed cell death 1 ligand 1 Tumor microenvironments
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!